72 related articles for article (PubMed ID: 3074955)
1. The effect of adjuvants on immune function in the multi-low-dose streptozotocin model of murine diabetes.
Richens ER; Behbehani K
Int J Tissue React; 1988; 10(4):207-16. PubMed ID: 3074955
[TBL] [Abstract][Full Text] [Related]
2. Expression and immune response to islet antigens following treatment with low doses of streptozotocin in H-2d mice.
Herold KC; Baumann E; Vezys V; Buckingham F
J Autoimmun; 1997 Feb; 10(1):17-25. PubMed ID: 9080296
[TBL] [Abstract][Full Text] [Related]
3. Effects of vaccination with heat shock proteins on streptozotocin induced diabetes in histidine decarboxylase knockout mice.
Szebeni A; Prohászka Z; Buzás E; Falus A; Kecskeméti V
Inflamm Res; 2008 Apr; 57(4):178-82. PubMed ID: 18351435
[TBL] [Abstract][Full Text] [Related]
4. Beta-cell apoptosis is responsible for the development of IDDM in the multiple low-dose streptozotocin model.
O'Brien BA; Harmon BV; Cameron DP; Allan DJ
J Pathol; 1996 Feb; 178(2):176-81. PubMed ID: 8683386
[TBL] [Abstract][Full Text] [Related]
5. S-methyl-L-thiocitrulline counteracts interleukin 1 beta induced suppression of pancreatic islet function in vitro, but does not protect against multiple low-dose streptozotocin-induced diabetes in vivo.
Sternesjö J; Welsh N; Sandler S
Cytokine; 1997 May; 9(5):352-9. PubMed ID: 9195135
[TBL] [Abstract][Full Text] [Related]
6. Reduction of oxidative stress by a new low-molecular-weight antioxidant improves metabolic alterations in a nonobese mouse diabetes model.
Novelli M; D'Aleo V; Lupi R; Paolini M; Soleti A; Marchetti P; Masiello P
Pancreas; 2007 Nov; 35(4):e10-7. PubMed ID: 18090226
[TBL] [Abstract][Full Text] [Related]
7. c-Jun amino terminal kinase 1 deficient mice are protected from streptozotocin-induced islet injury.
Fukuda K; Tesch GH; Nikolic-Paterson DJ
Biochem Biophys Res Commun; 2008 Feb; 366(3):710-6. PubMed ID: 18082135
[TBL] [Abstract][Full Text] [Related]
8. Complete Freund's adjuvant has a differential amplification action on the induction of diabetes by streptozotocin in various murine strains: CFA amplifies STZ in murine diabetes.
Richens ER; Tungekar MF; Behbehani K
Pathology; 1987 Oct; 19(4):351-7. PubMed ID: 3328141
[TBL] [Abstract][Full Text] [Related]
9. Essential pathogenic role of endogenous IL-18 in murine diabetes induced by multiple low doses of streptozotocin. Prevention of hyperglycemia and insulitis by a recombinant IL-18-binding protein: Fc construct.
Nicoletti F; Di Marco R; Papaccio G; Conget I; Gomis R; Bernardini R; Sims JE; Shoenfeld Y; Bendtzen K
Eur J Immunol; 2003 Aug; 33(8):2278-86. PubMed ID: 12884303
[TBL] [Abstract][Full Text] [Related]
10. IL-23 leads to diabetes induction after subdiabetogenic treatment with multiple low doses of streptozotocin.
Mensah-Brown EP; Shahin A; Al-Shamisi M; Wei X; Lukic ML
Eur J Immunol; 2006 Jan; 36(1):216-23. PubMed ID: 16358360
[TBL] [Abstract][Full Text] [Related]
11. A longitudinal ultrastructural study of pancreatic cellular damage in murine streptozotocin diabetes.
Richens ER; Tungekar FM; Behbehani K
Acta Diabetol Lat; 1988; 25(3):185-95. PubMed ID: 3071064
[TBL] [Abstract][Full Text] [Related]
12. CD28/B7 costimulation regulates autoimmune diabetes induced with multiple low doses of streptozotocin.
Herold KC; Vezys V; Koons A; Lenschow D; Thompson C; Bluestone JA
J Immunol; 1997 Jan; 158(2):984-91. PubMed ID: 8993020
[TBL] [Abstract][Full Text] [Related]
13. Upregulation of renal renin-angiotensin system in mouse diabetic nephropathy.
Tamura J; Konno A; Hashimoto Y; Kon Y
Jpn J Vet Res; 2005 Aug; 53(1-2):13-26. PubMed ID: 16190318
[TBL] [Abstract][Full Text] [Related]
14. Effect of cerebrocrast, a new long-acting compound on blood glucose and insulin levels in rats when administered before and after STZ-induced diabetes mellitus.
Briede J; Stivrina M; Stoldere Dz; Vigante B; Duburs G
Cell Biochem Funct; 2007; 25(6):673-80. PubMed ID: 16986170
[TBL] [Abstract][Full Text] [Related]
15. Newly weaned nonobese diabetic mice show heightened early diabetes sensitivity to multiple low doses of streptozotocin than nondiabetes-prone CD-1 mice: initial beta-cell damage a key trigger for type 1 diabetes?
Reddy S; Elliott RB; Chang M; Hsu T; Rodrigues JA; Qiao L; Robinson E
Pancreas; 2008 Jul; 37(1):e8-e19. PubMed ID: 18580436
[TBL] [Abstract][Full Text] [Related]
16. Preventative effects of the flowers of Inula britannica on autoimmune diabetes in C57BL/KsJ mice induced by multiple low doses of streptozotocin.
Kobayashi T; Song QH; Hong T; Kitamura H; Cyong JC
Phytother Res; 2002 Jun; 16(4):377-82. PubMed ID: 12112297
[TBL] [Abstract][Full Text] [Related]
17. A model for diabetic nephropathy: advantages of the inducible cAMP early repressor transgenic mouse over the streptozotocin-induced diabetic mouse.
Inada A; Kanamori H; Arai H; Akashi T; Araki M; Weir GC; Fukatsu A
J Cell Physiol; 2008 May; 215(2):383-91. PubMed ID: 18270980
[TBL] [Abstract][Full Text] [Related]
18. Loss of glucose transporter-2 precedes insulin loss in the nonobese diabetic and the low-dose streptozotocin mouse models: a comparative immunohistochemical study by light and confocal microscopy.
Reddy S; Young M; Poole CA; Ross JM
Gen Comp Endocrinol; 1998 Jul; 111(1):9-19. PubMed ID: 9653017
[TBL] [Abstract][Full Text] [Related]
19. Young NOD mice show increased diabetes sensitivity to low doses of streptozotocin.
Reddy S; Chang M; Robinson E
Ann N Y Acad Sci; 2006 Oct; 1079():109-13. PubMed ID: 17130539
[TBL] [Abstract][Full Text] [Related]
20. Renal effects of a neutralising RAGE-antibody in long-term streptozotocin-diabetic mice.
Jensen LJ; Denner L; Schrijvers BF; Tilton RG; Rasch R; Flyvbjerg A
J Endocrinol; 2006 Mar; 188(3):493-501. PubMed ID: 16522729
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
